newsfilter
← Latest News
GlobeNewswire·

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed